First Appendectomy Using Revolve Surgical Robotic Arm
ConditionAppendicitis Acute
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-40
SponsorUnity Health Toronto
About this trial
This study is testing a new surgical device called the Revolve Surgical System (RSS) during appendix removal surgery. The RSS is designed to help surgeons perform minimally invasive surgery with improved precision and stability while working at the patient's bedside, similar to standard laparoscopic surgery but with robotic assistance.
This will be the first time the device is used in patients. It will be evaluated in three adults with uncomplicated appendicitis who are already scheduled to have an appendectomy. The purpose of the study is to assess whether the device can be used safely and effectively and to better understand how it performs during surgery.
Eligibility criteria
Qualifiers
Inpatients at Unity Health Toronto - St. Michael's Hospital scheduled for an elective appendectomy
Ages of 21-40 years old
Male and non-pregnant female patients (pregnancy test required)
No co-morbidities
Disqualifiers
Any patient who does not have all the inclusion criteria described above.
Imaging of perforated appendix, free air, phlegmon, abscess, fluid collection, other any abdominal disease.
Any other abnormal laboratory test performed pre-operatively will cause the exclusion of the patient from the study.
Trial design
Treatments tested in this trial
- Revolve Surgical System - RSS
Treatment groups
3 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Unity Health Toronto
Lead sponsor
Revolve Surgical Inc.
Collaborator
Source ClinicalTrials.gov